Trial Outcomes & Findings for Bioequivalence Study for Benzyl Alcohol Lotion 5%. (NCT NCT02624843)
NCT ID: NCT02624843
Last Updated: 2021-01-27
Results Overview
Successful elimination of infestation by active treatment \[Time frame: 22 + 2 days\]. No evidence of active head lice infestation 22 days after enrollment.
Recruitment status
COMPLETED
Study phase
PHASE3
Target enrollment
239 participants
Primary outcome timeframe
Study Day 22 +/-2
Results posted on
2021-01-27
Participant Flow
Participant milestones
| Measure |
Benzyl Alcohol Lotion 5%
Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.
Benzyl Alcohol Lotion 5%: White topical lotion
|
Ulesfia (Benzyl Alcohol Lotion 5%)
Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.
Ulesfia (benzyl alcohol lotion) 5%: White topical lotion
|
Vehicle Placebo Lotion 0%
Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.
Placebo: White topical lotion
|
|---|---|---|---|
|
Overall Study
STARTED
|
107
|
108
|
24
|
|
Overall Study
COMPLETED
|
70
|
72
|
16
|
|
Overall Study
NOT COMPLETED
|
37
|
36
|
8
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Bioequivalence Study for Benzyl Alcohol Lotion 5%.
Baseline characteristics by cohort
| Measure |
Benzyl Alcohol Lotion 5%
n=107 Participants
Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.
Benzyl Alcohol Lotion 5%: White topical lotion
|
Ulesfia (Benzyl Alcohol Lotion 5%)
n=108 Participants
Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.
Ulesfia (benzyl alcohol lotion) 5%: White topical lotion
|
Vehicle Placebo Lotion 0%
n=24 Participants
Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.
Placebo: White topical lotion
|
Total
n=239 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Categorical
<=18 years
|
77 Participants
n=5 Participants
|
85 Participants
n=7 Participants
|
18 Participants
n=5 Participants
|
180 Participants
n=4 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
30 Participants
n=5 Participants
|
23 Participants
n=7 Participants
|
6 Participants
n=5 Participants
|
59 Participants
n=4 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Sex: Female, Male
Female
|
102 Participants
n=5 Participants
|
98 Participants
n=7 Participants
|
24 Participants
n=5 Participants
|
224 Participants
n=4 Participants
|
|
Sex: Female, Male
Male
|
5 Participants
n=5 Participants
|
10 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
15 Participants
n=4 Participants
|
|
Region of Enrollment
United States
|
107 participants
n=5 Participants
|
108 participants
n=7 Participants
|
24 participants
n=5 Participants
|
239 participants
n=4 Participants
|
PRIMARY outcome
Timeframe: Study Day 22 +/-2Population: PP
Successful elimination of infestation by active treatment \[Time frame: 22 + 2 days\]. No evidence of active head lice infestation 22 days after enrollment.
Outcome measures
| Measure |
Benzyl Alcohol Lotion 5%
n=70 Participants
Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.
Benzyl Alcohol Lotion 5%: White topical lotion
|
Ulesfia (Benzyl Alcohol Lotion 5%)
n=72 Participants
Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.
Ulesfia (benzyl alcohol lotion) 5%: White topical lotion
|
Vehicle Placebo Lotion 0%
n=16 Participants
Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.
Placebo: White topical lotion
|
|---|---|---|---|
|
Number of Participants With Infestation Successfully Eliminated by Active Treatment.
|
59 Participants
|
57 Participants
|
6 Participants
|
Adverse Events
Benzyl Alcohol Lotion 5%
Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths
Ulesfia (Benzyl Alcohol Lotion 5%)
Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths
Vehicle Placebo Lotion 0%
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Benzyl Alcohol Lotion 5%
n=107 participants at risk
Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.
Benzyl Alcohol Lotion 5%: White topical lotion
|
Ulesfia (Benzyl Alcohol Lotion 5%)
n=108 participants at risk
Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.
Ulesfia (benzyl alcohol lotion) 5%: White topical lotion
|
Vehicle Placebo Lotion 0%
n=24 participants at risk
Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out.
Placebo: White topical lotion
|
|---|---|---|---|
|
Skin and subcutaneous tissue disorders
Skin, nervous system and general disorder
|
0.93%
1/107 • Number of events 1
|
0.00%
0/108
|
0.00%
0/24
|
|
Eye disorders
redness of eye
|
0.93%
1/107 • Number of events 1
|
0.00%
0/108
|
0.00%
0/24
|
|
General disorders
fever
|
0.00%
0/107
|
0.93%
1/108 • Number of events 1
|
0.00%
0/24
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place